TABLE 1

Epidermal growth factor receptor mutations with their relative frequency and sensitivity to tyrosine kinase inhibitor (TKI)

MutationFrequencyDrug activityReferences
Exon 19 deletions#45%Sensitive to first generation TKICosta et al. [13], 2007
L858R40%Rosell et al. [14], 2009
Maemondo et al. [15], 2010
Mitsudomi et al. [16], 2010
Mok et al. [17], 2009
Zhou et al. [18], 2011
Sequist et al. [19], 2013
In frame insertions exon 192%Sensitive to first generation TKIHe et al. [20], 2012
G719X (A/C/S)2–3%Sensitive to first generation TKIWatanabe et al. [21], 2014
Possibly shorter response time
L861 Q2%Sensitive to first generation TKIDe Pas et al. [22], 2011
Pao and Chmielecki [23], 2010
L861 RRareResistance?De Pas et al. [22], 2011
Exon 20 in frame insertions2%; up to 10% in some seriesResistance to first generation TKIPao and Chmielecki [23], 2010
Some - A763_Y764insFQEA - are sensitive to TKIOxnard et al. [24], 2013
Arcila et al. [25], 2013
Yasuda et al. [26], 2012
Yasuda et al. [27], 2013
T790M∼50% in progressing patients under TKI
Rare in untreated patients
Resistance if secondary to treatment
Negative impact on response rate and survival: may sometimes respond to first generation TKI
Sun et al. [28], 2013
Yu et al. [29], 2014
Ding et al. [30], 2014
D761YRareUncertain significance, possible partial resistanceBalak et al. [31], 2006
L747 P/SRareUncertain significance, possible partial resistancevan der Wekken et al. [32], 2012
Costa et al. [33], 2007
Costa et al. [34], 2008
S768IRareResistance to first generation TKI?Shigematsu et al. [35], 2005
Sensitive to afatinib?De Pas et al. [22], 2011
May occur in association with other mutationsJ.C. Yang and co-workers, personal communication
E709 A/VRareResistance?Shigematsu et al. [35], 2005
Occur in association with other activating mutations
H870RRareResistance?De Pas et al. [22], 2011
Occur with other mutations
Shorten response time
Other mutations: S720F, I715S, L862V, S784FRareUnknownShigematsu et al. [35], 2005
De Pas et al. [22], 2011
Tsao et al. [36], 2005
Ludovini et al. [37], 2008
Compound mutationsFrequency unknown; few data exist and are mainly based on case reports
  • #:There are several variants of exon 19 in frame deletions, some of them not encompassing the LRE region. Response to therapy may be different according to mutation type [38].